Specify a stock or a cryptocurrency in the search bar to get a summary
Nanjing Vazyme Biotech Co Ltd
688105Nanjing Vazyme Biotech Co., Ltd offers technology solutions for life science, biomedicine, and in vitro diagnostics. The company offers reagents for molecular biology research, such as nucleic acid extraction, PCR, cloning/mutagenesis, nucleic acid electrophoresis, reverse transcription, real-time PCR (qPCR), genome editing, and cell biology/protein research; reagents for NGS library preparation, including automated liquid handling workstation, DNA sequencing, RNA sequencing, single cell-seq series, epigenetics series, beads series, quantification series, and capture series; reagents for molecular diagnosis comprising isothermal amplification reagents, PCR, reverse transcription, real-time PCR, one-step series, and animal detection; and reagents for bio-medicine, such as vaccine effectiveness evaluations and vaccine manufacture. Nanjing Vazyme Biotech Co., Ltd was founded in 2012 and is based in Nanjing, China. Address: Building D2, Nanjing, China, 210033
Analytics
WallStreet Target Price
178.21 CNYP/E ratio
425.6667Dividend Yield
0.41 %Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures 688105
Dividend Analytics 688105
Dividend growth over 5 years
–Continuous growth
1 yearPayout Ratio 5 years average
-341 %Dividend History 688105
Stock Valuation 688105
Financials 688105
Results | 2019 | Dynamics |